Cubist Systematic Strategies, LLC Corcept Therapeutics Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $2.5 Million - $3.26 Million	118,690 Added 51.01%	351,374 $8.85 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $1.38 Million - $1.82 Million	-55,494 Reduced 19.26%	232,684 $7.56 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $4.13 Million - $6.36 Million	188,189 Added 188.21%	288,178 $7.85 Million
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $86,553 - $101,530	-4,037 Reduced 3.88%	99,989 $2.22 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $3.06 Million - $3.9 Million	-159,472 Reduced 60.52%	104,026 $2.25 Million
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $2.83 Million - $4.26 Million	142,044 Added 116.95%	263,498 $5.35 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $1.32 Million - $1.56 Million	-53,419 Reduced 30.55%	121,454 $3.11 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $2.27 Million - $3.32 Million	-131,139 Reduced 42.85%	174,873 $4.16 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $2.55 Million - $3.89 Million	154,184 Added 101.55%	306,012 $6.89 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $1.65 Million - $2.25 Million	96,570 Added 174.76%	151,828 $3.01 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $572,904 - $655,870	29,111 Added 111.34%	55,258 $1.09 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $353,828 - $432,850	17,718 Added 210.2%	26,147 $575,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $19,026 - $24,753	-810 Reduced 8.77%	8,429 $201,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $355,668 - $578,650	-21,196 Reduced 69.64%	9,239 $242,000
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $1.15 Million - $1.84 Million	-92,293 Reduced 75.2%	30,435 $530,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $385,935 - $640,652	35,085 Added 40.03%	122,728 $2.06 Million
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $139,315 - $193,471	-13,780 Reduced 13.59%	87,643 $1.04 Million
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $46,394 - $65,245	3,847 Added 3.94%	101,423 $1.23 Million
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $743,575 - $1.05 Million	71,429 Added 273.18%	97,576 $1.38 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $252,822 - $329,858	-25,851 Reduced 49.72%	26,147 $292,000
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $156,658 - $245,374	15,619 Added 42.93%	51,998 $610,000
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $410,718 - $625,355	36,379 New	36,379 $486,000
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $229,267 - $400,707	-15,714 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $147,701 - $194,063	-9,366 Reduced 37.34%	15,714 $284,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $308,484 - $484,044	25,080	25,080 $484,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$850 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$514 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$425 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$335 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$196 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account